MediWound Ltd.
MDWD
$17.45
-$0.255-1.44%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -124.21% | -788.32% | 76.63% | 47.70% | |
| Total Depreciation and Amortization | 14.74% | 13.33% | 21.83% | 0.30% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 35.87% | 157.35% | -120.86% | -158.32% | |
| Change in Net Operating Assets | 240.12% | 83.98% | 175.39% | 75.17% | |
| Cash from Operations | 37.40% | 31.00% | -230.75% | 28.80% | |
| Capital Expenditure | 63.51% | -183.19% | -1,169.54% | -1,930.12% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -22.15% | 123.43% | 181.60% | -138,200.00% | |
| Cash from Investing | -3.98% | 110.91% | 109.85% | -7,185.00% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -18.63% | -36.31% | -20.00% | -32.60% | |
| Issuance of Common Stock | -- | -- | -100.00% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 100.00% | -407.29% | |
| Cash from Financing | -151.47% | 74.57% | -101.39% | -106.17% | |
| Foreign Exchange rate Adjustments | -99.47% | 87.50% | 959.09% | -280.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 3.59% | 97.19% | -86.38% | -237.78% | |